We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+10.65%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
AUM
$265M
AUM Growth
+$133M
Cap. Flow
+$124M
Cap. Flow %
46.58%
Top 10 Hldgs %
51.96%
Holding
111
New
4
Increased
98
Reduced
Closed

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$21.2M
2
MSFT icon
Microsoft
MSFT
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.2M
4
MCO icon
Moody's
MCO
+$6.32M
5
TRI icon
Thomson Reuters
TRI
+$4.66M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Healthcare 20.67%
3 Financials 14.72%
4 Energy 11.12%
5 Communication Services 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.39M 0.9%
4,080
+1,915
+88% +$1.09M
SYF icon
27
Synchrony
SYF
$23.7B
$2.34M 0.88%
39,150
+19,350
+98% +$1.08M
ALKT icon
28
Alkami Technology
ALKT
$1.8B
$2.26M 0.85%
80,205
+38,795
+94% +$1.08M
META icon
29
Meta Platforms (Facebook)
META
$1.51T
$2.23M 0.84%
3,400
+1,700
+100% +$1.05M
ABNB icon
30
Airbnb
ABNB
$83.7B
$2.23M 0.84%
17,700
+8,850
+100% +$1.12M
ACLS icon
31
Axcelis
ACLS
$4.12B
$2.15M 0.81%
36,535
+16,895
+86% +$964K
FBP icon
32
First Bancorp
FBP
$4.4B
$2.14M 0.81%
107,200
+52,600
+96% +$1.03M
OKE icon
33
Oneok
OKE
$58.7B
$2.11M 0.8%
23,345
+11,510
+97% +$960K
ABBV icon
34
AbbVie
ABBV
$458B
$2.08M 0.79%
10,546
+5,273
+100% +$980K
MESO
35
Mesoblast
MESO
$1.99B
$2.05M 0.77%
175,350
+87,675
+100% +$982K
QQQ icon
36
Invesco QQQ Trust
QQQ
$455B
$2.03M 0.77%
3,990
+1,945
+95% +$967K
USAC icon
37
USA Compression Partners
USAC
$3.82B
$2.01M 0.76%
78,314
+38,838
+98% +$963K
AEHR icon
38
Aehr Test Systems
AEHR
$2.48B
$1.93M 0.73%
167,625
+126,250
+305% +$1.2M
COOP
39
DELISTED
Mr. Cooper
COOP
$1.89M 0.71%
15,825
HESM icon
40
Hess Midstream
HESM
$5.22B
$1.86M 0.7%
46,060
+23,030
+100% +$877K
ASUR icon
41
Asure Software
ASUR
$220M
$1.86M 0.7%
192,645
+89,660
+87% +$863K
DAIO icon
42
Data I/O
DAIO
$32M
$1.74M 0.66%
619,200
+349,750
+130% +$881K
AAPL icon
43
Apple
AAPL
$4.89T
$1.73M 0.65%
8,108
+4,054
+100% +$819K
COHU icon
44
Cohu
COHU
$2.39B
$1.49M 0.56%
89,100
+38,800
+77% +$654K
ELVA
45
Electrovaya
ELVA
$412M
$1.47M 0.56%
490,326
+308,111
+169% +$906K
NVGS icon
46
Navigator Holdings
NVGS
$1.34B
$1.41M 0.53%
102,700
+50,400
+96% +$679K
NVDA icon
47
NVIDIA
NVDA
$5.01T
$1.39M 0.52%
10,446
+5,223
+100% +$657K
SHEL icon
48
Shell
SHEL
$245B
$1.39M 0.52%
19,300
+9,400
+95% +$630K
NVS icon
49
Novartis
NVS
$295B
$1.32M 0.5%
11,370
+5,610
+97% +$632K
EMR icon
50
Emerson Electric
EMR
$82.9B
$1.31M 0.49%
10,800
+5,400
+100% +$620K

Similar funds

Penbrook Management's Q2 2025 Portfolio in Review

As of Q2 2025, Penbrook Management held 111 positions worth $265M, up 101% from $132M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Penbrook Management deployed $124M of net new capital in Q2 2025, opening 4 new positions and adding to 98 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 3,500 shares worth $254K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Penbrook Management's largest Q2 2025 buy was State Street SPDR Portfolio S&P 500 ETF: 3,500 shares worth $254K.
  • Penbrook Management added most to Novo Nordisk in Q2 2025, an estimated $21.2M increase.
  • Penbrook Management's ten largest holdings make up 52% of its $265M portfolio in Q2 2025.
  • Penbrook Management opened 4 new positions and closed 0 in Q2 2025.
  • Penbrook Management's portfolio value rose 101% quarter-over-quarter to $265M.

Based on Penbrook Management's 13F filing for Q2 2025, filed 25 Jul 2025.